Aligos Therapeutics Inc. logo

Aligos Therapeutics Inc. (ALGS)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 08
0
0%
$
25.25M Market Cap
- P/E Ratio
- Div Yield
212,999 Volume
-10.36 Eps
$ 4.08
Previous Close
Analysts:
Add Transaction
Day Range
3.98 4.27
Year Range
3.98 13.69
Want to track ALGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Aligos Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
83,055 $719,256 $452,234.47 -$267,021.53 -37.12%
NM
Nir Messafi Deep Track Capita LLP
444,110 $3.76M $2.42M -$1.35M -35.75%
Drew Phillips
Drew Phillips Fortitude Family Office LLC
68 $505 $390.32 -$114.68 -22.71%
Andrew Kirchner
Andrew Kirchner ELEVATION WEALTH PARTNERS, LLC
4 $35 $21.76 -$13.24 -37.83%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
950 $7,059 $5,016 -$2,043 -28.94%
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
148,799 $1.37M $800,538.62 -$568,549.66 -41.53%